<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.7: Neuro-Endocrinology Research: Hormones, Mood, and Cognition</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Neuro-Endocrinology */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #8b5cf6, #6d28d9);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #4c1d95;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f5f3ff;
            border-radius: 8px;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: #666;
        }

        .ref-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 13px;
            color: #555;
            line-height: 1.6;
        }

        .ref-list li {
            margin-bottom: 10px;
            padding-left: 15px;
            position: relative;
        }

        .ref-list li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #6d28d9;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2 Research & Evidence</p>
            <h1 class="lesson-title">Lesson 7: Neuro-Endocrinology Research: Hormones, Mood, and Cognition</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 7 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Window of Opportunity</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Neurosteroids & GABA Sensitivity</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Estrogen & Neurotransmitters</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Debunking 'Adrenal Fatigue'</a></li>
                <li><a href="#section5"><span class="section-num">5</span>fMRI Evidence in Menopause</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Evidence-Based Interventions</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the "Window of Opportunity" hypothesis for neuroprotection and Alzheimer's prevention.</li>
                <li>Understand the biochemical link between Allopregnanolone, GABA-A receptors, and PMDD/PPD.</li>
                <li>Differentiate between the clinical literature on HPA Axis Dysregulation versus the colloquial "Adrenal Fatigue."</li>
                <li>Review fMRI data demonstrating how estrogen fluctuations alter serotonin and dopamine signaling.</li>
                <li>Evaluate lifestyle interventions for optimizing sleep architecture and mitigating hormonal "brain fog."</li>
            </ul>
        </div>

        <h2 id="section1">1. The 'Window of Opportunity' for Neuroprotection</h2>
        <p>One of the most significant shifts in neuro-endocrinology research over the last decade is the refinement of the <span class="highlight">Window of Opportunity Hypothesis</span>. Following the initial reporting of the Womenâ€™s Health Initiative (WHI) in 2002, there was a widespread belief that Hormone Replacement Therapy (HRT) might increase the risk of dementia. However, subsequent re-analysis and new trials like the <strong>KEEPS</strong> (Kronos Early Estrogen Prevention Study) and <strong>ELITE</strong> (Early versus Late Intervention Trial with Estradiol) have fundamentally changed this narrative.</p>

        <p>The research now suggests that the timing of hormone initiation is the critical determinant of neurological outcomes. When estradiol is introduced during the <span class="highlight">perimenopausal transition</span> or within the first five years of menopause, it appears to exert a neuroprotective effect, potentially reducing the risk of Alzheimerâ€™s Disease (AD) and cognitive decline. Conversely, initiating HRT 10-15 years after the onset of menopause, when the brain has already undergone significant estrogen deprivation and potentially irreversible synaptic changes, may be neutral or even detrimental.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Reduction in AD Risk (Early HRT)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10yr</div>
                    <div class="stat-label">Critical Window Post-Menopause</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">64%</div>
                    <div class="stat-label">Women reporting 'Brain Fog'</div>
                </div>
            </div>
        </div>

        <h2 id="section2">2. Neurosteroids: Allopregnanolone and GABA-A Receptors</h2>
        <p>While we often think of progesterone as a "calming" hormone, its true neurological impact is mediated through its metabolite, <span class="highlight">Allopregnanolone (ALLO)</span>. ALLO is a potent positive allosteric modulator of the <strong>GABA-A receptor</strong>. In a healthy neuro-endocrine system, ALLO enhances the inhibitory effect of GABA, leading to reduced anxiety and improved sleep.</p>

        <p>However, research into <strong>Premenstrual Dysphoric Disorder (PMDD)</strong> and Postpartum Depression (PPD) has revealed that certain women possess a genetic or functional sensitivity to the *fluctuations* of ALLO rather than the absolute levels. In PMDD, the rapid drop in ALLO during the late luteal phase triggers a paradoxical response in the GABA-A receptor, leading to severe irritability and depression. This research led to the 2019 FDA approval of <strong>Brexanolone</strong>, a synthetic version of allopregnanolone, which demonstrated a rapid (within 48 hours) reduction in PPD symptoms in clinical trials (n=246, p<0.01).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§ </div>
                <div>
                    <p class="box-label">Case Study: The PMDD Paradox</p>
                    <p class="subtitle">Neurosteroid Sensitivity Assessment</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 32</h4>
                        <p>Symptoms: Severe luteal-phase anxiety, suicidal ideation 3 days before menses, insomnia.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Utilizing "The Method" framework, Sarah's practitioner identified a "Sensitivity Phenotype" rather than a hormone deficiency. Instead of high-dose progesterone, the intervention focused on stabilizing the ALLO-GABA interface through micronized progesterone (to provide a steady baseline) and calcium/magnesium supplementation shown in meta-analyses to stabilize GABAergic signaling.</p>
                <p><strong>Outcome:</strong> 60% reduction in "Daily Record of Severity of Problems" (DRSP) scores over three cycles.</p>
            </div>
        </div>

        <h2 id="section3">3. Estrogen's Influence on Serotonin and Dopamine</h2>
        <p>Estradiol is not merely a reproductive hormone; it is a master regulator of neurotransmission. Research using <strong>functional MRI (fMRI)</strong> and PET scans has shown that estrogen influences the brain in three primary ways:</p>
        <ol class="content-list">
            <li><strong>Synthesis:</strong> Estrogen upregulates the enzyme <em>tryptophan hydroxylase</em>, the rate-limiting step in serotonin production.</li>
            <li><strong>Degradation:</strong> It inhibits <em>Monoamine Oxidase (MAO)</em>, the enzyme that breaks down serotonin and dopamine, effectively keeping these "feel-good" chemicals in the synapse longer.</li>
            <li><strong>Receptor Density:</strong> High-estrogen states are correlated with increased density of serotonin (5-HT2A) receptors in the prefrontal cortex and hippocampus.</li>
        </ol>

        <p>This explains why the perimenopausal "estrogen roller coaster" often manifests as clinical depression or ADHD-like symptoms. When estrogen levels crash, serotonin levels follow suit, leading to the irritability and "low mood" characteristic of the transition. Furthermore, estrogenâ€™s role in dopamine signaling in the <strong>nucleus accumbens</strong> explains the loss of motivation and "anhedonia" often reported by postmenopausal women.</p>

        <h2 id="section4">4. Cortisol and the HPA Axis: Beyond 'Adrenal Fatigue'</h2>
        <p>In the wellness industry, "Adrenal Fatigue" is a ubiquitous term. However, in the clinical literature, this term is largely rejected in favor of <span class="highlight">HPA Axis Dysregulation</span>. The distinction is critical for the Hormone Health Coach. The adrenal glands rarely "fail" or "tire out" (except in Addison's Disease); instead, the brainâ€”specifically the hypothalamus and pituitaryâ€”re-calibrates its signaling in response to chronic stress.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Colloquial 'Adrenal Fatigue'</th>
                        <th>Clinical HPA Dysregulation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Mechanism</strong></td>
                        <td>Adrenals are "worn out" and can't produce cortisol.</td>
                        <td>Adaptive brain-signaling change (feedback loop resistance).</td>
                    </tr>
                    <tr>
                        <td><strong>Cortisol Levels</strong></td>
                        <td>Always assumed to be low.</td>
                        <td>Can be high (Hypercortisolism) or low (Hypocortisolism).</td>
                    </tr>
                    <tr>
                        <td><strong>Evidence Base</strong></td>
                        <td>Anecdotal; not recognized by endocrine societies.</td>
                        <td>Extensive research on "Allostatic Load" and cortisol rhythms.</td>
                    </tr>
                    <tr>
                        <td><strong>Primary Driver</strong></td>
                        <td>The Adrenal Gland.</td>
                        <td>The Central Nervous System (Hypothalamus).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A 2016 systematic review of 58 studies found no substantiation for the term "Adrenal Fatigue." However, research into <strong>Diurnal Cortisol Slopes</strong> shows that a "flat" slope (high night cortisol, low morning cortisol) is strongly correlated with systemic inflammation, breast cancer progression, and cognitive impairment. As practitioners, we must use the evidence-based language of "HPA Dysfunction" to maintain clinical credibility.</p>

        <h2 id="section5">5. fMRI Evidence: The Menopausal Brain Shift</h2>
        <p>Groundbreaking fMRI studies by Dr. Lisa Mosconi and colleagues have visualized the "bioenergetic shift" that occurs in the female brain during the menopausal transition. These studies demonstrate a <span class="highlight">30-40% reduction in brain glucose metabolism</span> during perimenopause. This is not due to a lack of glucose in the blood, but rather a decrease in the brain's ability to <em>utilize</em> glucose as fuel, a process heavily dependent on estrogen.</p>
        
        <p>This "hypometabolism" explains the cognitive symptoms of "Brain Fog." The brain is essentially undergoing a metabolic re-patterning. Interestingly, women who are "ApoE4 positive" (a genetic risk factor for Alzheimer's) show significantly more pronounced drops in brain energy during this window, further reinforcing the "Window of Opportunity" for intervention.</p>

        <h2 id="section6">6. Evidence-Based Lifestyle Interventions for Brain Health</h2>
        <p>While HRT is a powerful tool, the research into non-pharmacological interventions for neuro-endocrine health is robust. Two areas stand out: <strong>Sleep Architecture</strong> and <strong>Exercise-Induced BDNF</strong>.</p>

        <p><strong>Sleep Architecture:</strong> Menopausal hormonal shifts (specifically low progesterone) lead to a decrease in <em>Slow Wave Sleep (SWS)</em>. Research shows that SWS is the period when the <strong>Glymphatic System</strong> (the brain's waste clearance system) is most active, clearing out amyloid-beta plaques. Interventions like Magnesium Bisglycinate (300-400mg) and maintaining a consistent circadian rhythm are proven to improve SWS duration.</p>

        <p><strong>Exercise & BDNF:</strong> Brain-Derived Neurotrophic Factor (BDNF) is often called "Miracle-Gro for the brain." A 2022 meta-analysis found that high-intensity interval training (HIIT) combined with resistance training increased serum BDNF levels by 15-20% in perimenopausal women, directly counteracting the synaptic loss associated with declining estrogen.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. Why does the timing of HRT initiation matter for Alzheimer's prevention, according to the 'Window of Opportunity' hypothesis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The brain is most receptive to the neuroprotective effects of estrogen early in the transition. If estrogen is absent for too long (10+ years), the brain undergoes structural changes and loses estrogen receptors, making late-stage HRT less effective or potentially risky for cognitive health.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the biochemical mechanism by which Allopregnanolone affects mood?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Allopregnanolone is a metabolite of progesterone that acts as a positive allosteric modulator of GABA-A receptors. It enhances the calming effect of GABA, but rapid fluctuations can trigger paradoxical anxiety/depression in sensitive individuals (PMDD).
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The "Window of Opportunity" suggests HRT is most neuroprotective when started within 5-10 years of menopause.</li>
                <li>PMDD is often a sensitivity to neurosteroid (Allopregnanolone) fluctuations at the GABA-A receptor, not just "low hormones."</li>
                <li>Estrogen acts as a "neurotransmitter primer," increasing serotonin and dopamine levels and receptor sensitivity.</li>
                <li>"Adrenal Fatigue" is clinically inaccurate; "HPA Axis Dysregulation" describes the brain-driven shift in cortisol rhythms.</li>
                <li>Menopause involves a 30-40% drop in brain glucose metabolism, which can be mitigated by lifestyle and hormonal support.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Maki, P. M., & Henderson, V. W. (2016). "Hormone therapy and cognitive function." *Nature Reviews Endocrinology.*</li>
                <li>Meltzer-Brody, S., et al. (2019). "Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials." *The Lancet.*</li>
                <li>Mosconi, L., et al. (2021). "Menopause impacts human brain structure, connectivity and metabolism." *Nature Scientific Reports.*</li>
                <li>Cadegiani, F. A., & Kater, C. E. (2016). "Adrenal fatigue does not exist: a systematic review." *BMC Endocrine Disorders.*</li>
                <li>Brinton, R. D., et al. (2015). "The 'window of opportunity' for estrogen therapy in the brain." *Free Radical Biology and Medicine.*</li>
                <li>Epperson, C. N., et al. (2012). "Gonadal steroids and GABAergic neurotransmission." *Psychopharmacology.*</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Women's Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>